{{Rsnum
|rsid=2287498
|Gene=WRAP53
|Chromosome=17
|position=7689242
|Orientation=minus
|ReferenceAllele=C
|GMAF=0.1837
|Gene_s=TP53
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 3.1 | 15.4 | 81.5
| HCB | 11.1 | 42.2 | 46.7
| JPT | 6.7 | 33.3 | 60.0
| YRI | 9.5 | 42.9 | 47.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 11.1 | 42.2 | 46.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
A study population including a total of 5,206 invasive [[ovarian cancer]] cases (2,829 of which were serous) and 8,790 controls found an association between [[rs2287498]] and serous invasive cancer (median per allele odds ratio 1.30, CI: 1.07-1.57).{{PMID|19276375|OA=1
}}

{{PMID Auto
|PMID=20386703
|Title=Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer.
|OA=1
}}

{{PMID Auto
|PMID=23192612
|Title=Association of common WRAP 53 variant with ovarian cancer risk in the Polish population
|OA=1
}}

{{PMID Auto
|PMID=22773013
|Title=Genetic variants in TP53 and MDM2 associated with male infertility in Chinese population.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}